The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?
Yuko Oya, Kazuyoshi Imaizumi, Tetsuya Mitsudomi
Topics & Concepts
KRASMedicineCancer researchColorectal cancerCancerTyrosine kinaseMutationTargeted therapyReceptor tyrosine kinaseKinaseReceptorInternal medicineBiologyGeneticsGeneChronic Lymphocytic Leukemia ResearchPI3K/AKT/mTOR signaling in cancerCancer therapeutics and mechanisms